The proportion of apoptotic cells in FUBP1‐overexpressing osteosarcoma cells treated with lobaplatin was markedly reduced, whereas this proportion was increased in FUBP1‐silenced osteosarcoma cells (Figure S4A,B). Here, FUBP1 is linked to osteosarcoma.